Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0023890 (
cirrhosis
)
42,195
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Using spectrophotometric method, we studied the activities of serum alpha-L-fucosidase, N-acetyl-beta-D-glucosaminidase and
alpha-D-mannosidase
in 94 patients, of whom 32 had acute hepatitis, 4 subacute fulminant hepatitis, 27 chronic active hepatitis, 22 posthepatitic
cirrhosis
and 9 hepatocellular carcinoma. In comparison with normal controls, the activities of the three glycosidases in the patients were significantly increased. The degree of the elevation of alpha-L-fucosidase activity correlated to the clinical phases and the course of acute infection of hepatitis B virus (HBV). The levels of glycosidase activities could reflect to a certain degree the pathological variations of the liver. Monitoring the levels of glycosidase activities, especially alpha-L-fucosidase, would be helpful in the diagnosis and medical care of viral hepatitis and hepatocellular carcinoma.
...
PMID:Activities of serum enzymes in patients with viral hepatitis B, posthepatitic cirrhosis and hepatocellular carcinoma. 217 63
The activities of several glycosidases (alpha-L-fucosidase,
alpha-D-mannosidase
, alpha-D-galactosidase, beta-D-galactosidase, beta-N-acetylglucosaminidase and beta-D-glucuronidase) were determined in human sera from 10 normal subjects and in three groups each of 10 patients with diabetes mellitus,
hepatic cirrhosis
and gastric carcinoma. The results show significantly higher activities in the patients for alpha-L-fucosidase (p less than 0.001) and for beta-N-acetylglucosaminidase (p less than 0.1, p less than 0.001 and p less than 0.05, respectively), and smaller or not significantly greater values for the other glycosidases.
...
PMID:Increased serum alpha-L-fucosidase and beta-N-acetylglucosaminidase activities in diabetic, cirrhotic and gastric cancer patients. 624 16
Sera from 9 persons with either biopsy-proven alcoholic liver disease or a history of chronic, excessive ethanol consumption were analyzed for their content of various hydrolases. Compared to controls, significant elevations in the following enzyme activities were seen in sera from the patient population: acid phosphatase (2.0-fold), beta-glucuronidase (2.1-fold), hexosaminidase (1.4-fold), and alpha-L-fucosidase (2.3-fold). In addition,
alpha-mannosidase
activity, previously reported to be unchanged in cases of
hepatic cirrhosis
[Reglero et al., Clinica chim. Acta 130: 155-158], (1980) was found to be significantly increased (p less than 0.001) when assays were performed at acid (pH 4.5) or intermediate (pH 5.5) hydrogen ion concentrations. Fractionation of sera on DEAE-Sephadex columns showed that the increase in
alpha-mannosidase
activity in the serum of patients with alcoholic liver disease was due to increases in the level of at least one 'acid
alpha-mannosidase
' and two intermediate pH optimum alpha-mannosidases. The general increase in the activity of a group of glycosidases is consistent with a hypothesis involving decreased clearance of glycoproteins from the blood of persons with
hepatic cirrhosis
.
...
PMID:Serum alpha-mannosidase in patients with alcoholic liver disease. 671 94
Homogenates of liver from cases of
hepatic cirrhosis
due to alpha 1-antitrypsin deficiency (PiZZ) alcoholism were analyzed for their content of various lysosomal enzymes. Also determined were the specific activities of lactate dehydrogenase, glutamate-oxaloacetate transaminase, glutamate-pyruvate transaminase, and creatine phosphokinase in the extracts of liver from cases of both kinds of
hepatic cirrhosis
: all of these activities were within the range of control values. Similarly, the specific activities of the following lysosomal hydrolases were unremarkable: acid phosphatase, beta-mannosidase, beta-fucosidase, beta-glucuronidase and beta-glucosidase. Hexosaminidase specific activity was increased twofold in livers from the cases of
cirrhosis
due to alpha 1-antitrypsin deficiency. The specific activity of
alpha-mannosidase
(measured at pH 4.5) in homogenates of livers from PiZZ individuals with
cirrhosis
and those with alcoholic cirrhosis was increased two- to four-fold. Chromatography of the high-speed supernatant fraction from homogenates of livers of cirrhotic and noncirrhotic individuals on columns of DEAE-cellulose resolved
alpha-mannosidase
activity into two components: under the conditions employed, acid pH optimum (pH 4.5)
alpha-mannosidase
did not bind to the resin, whereas intermediate pH optimum (pH 5.5)
alpha-mannosidase
could be eluted with 0.1 mol/l NaCl. Liver from one case of (PiZZ) alpha 1-antitrypsin deficiency and emphysema, without demonstrable
cirrhosis
, was found to contain normal levels of both acid
alpha-mannosidase
and intermediate
alpha-mannosidase
. However, cases of
cirrhosis
due to alpha 1-antitrypsin deficiency contained twice as much acid
alpha-mannosidase
and only one third to one fourth as much intermediate
alpha-mannosidase
as controls. The deficiency in hepatic intermediate
alpha-mannosidase
was also observed in 5 of 5 cases of alcoholic cirrhosis.
...
PMID:Altered alpha-mannosidase isoenzymes in the liver in hepatic cirrhosis. 697 51